Prostate Cancer

The Pharmacy Times® Prostate Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancer that occurs in the prostate.

Latest News

Close up of prostate cancer cells - Image credit: Science RF | stock.adobe.com
FDA Approves 3-Month Leuprolide Mesylate 21-mg Formulation for Advanced Prostate Cancer

August 29th 2025

The FDA has approved a ready-to-use long-acting injectable formulation that is administered every 3 months as a treatment for advanced prostate cancer.

A Drug box of Xtandi containing Enzalutamide for treatment of prostate cancer on a table and in the background different medical books. Image Credit: omar | stock.adobe.com
Enzalutamide Plus Leuprolide Extends Survival in High-Risk Non-Metastatic Prostate Cancer

July 18th 2025

Conceptual image for prostate cancer treatment, 3D illustration showing destruction of a tumor inside prostate gland - Image credit: Dr_Microbe | stock.adobe.com
TRE-5151 Receives FDA Fast Track Designation in Combination With Radiation Therapy for Prostate Cancer

July 14th 2025

Darolutamide Approved by FDA for Metastatic Castration-Sensitive Prostate Cancer
Darolutamide Approved by FDA for Metastatic Castration-Sensitive Prostate Cancer

June 3rd 2025

Prostate disease and treatment. Male reproductive system anatomical model in doctors hands close-up during consultation of male patient with suspected bacterial prostatitis - Image credit: Peakstock | stock.adobe.com
Anti-Diabetic Drug Could Offer New Treatment for Prostate Cancer

May 20th 2025

Latest CME Events & Activities
<12345
© 2025 MJH Life Sciences

All rights reserved.